EyePoint Pharmaceuticals, Inc. - FORM 10-Q - EX-32.1 - CERTIFICATION OF THE PEO PURSUANT TO SECTION 906 - February 12, 2010

Attached files

file filename
10-Q - FORM 10-Q - EyePoint Pharmaceuticals, Inc.d10q.htm
EX-32.2 - CERTIFICATION OF THE PFO PURSUANT TO SECTION 906 - EyePoint Pharmaceuticals, Inc.dex322.htm
EX-31.2 - CERTIFICATION OF PFO PURSUANT TO SECTION 302 - EyePoint Pharmaceuticals, Inc.dex312.htm
EX-10.1 - PSIVIDA CORP. KEY EMPLOYEE ANNUAL BONUS PLAN - EyePoint Pharmaceuticals, Inc.dex101.htm
EX-31.1 - CERTIFICATION OF PEO PUSUANT TO SECTION 302 - EyePoint Pharmaceuticals, Inc.dex311.htm

Exhibit 32.1

Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

In connection with the Quarterly Report of pSivida Corp. (the “Company”) on Form 10-Q for the quarter ended December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Paul Ashton, President and Chief Executive Officer of the Company, certify that to the best of my knowledge:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: February 12, 2010
/s/ Paul Ashton
Name:   Paul Ashton
Title:   President and Chief Executive Officer
  (Principal Executive Officer)

Stock widget

Investing forum

EyePoint Pharmaceuticals, Inc. Reports

Also read